Detalhe da pesquisa
1.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol;
98(12): 1856-1868, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37772428
2.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol;
39(4): 570-574, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34258787
3.
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.
Int J Cancer;
135(12): 2834-46, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24771328
4.
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
Blood;
120(16): 3271-9, 2012 Oct 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22932792
5.
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.
Haematologica;
99(10): 1605-10, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24972771
6.
Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αß CD8+ T cells, regulatory T cells, and dendritic cells.
J Immunol;
187(4): 1578-90, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21753152
7.
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
J Hematol Oncol;
15(1): 116, 2022 08 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36028857
8.
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases.
Clin Case Rep;
9(3): 1066-1071, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33768784
9.
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Leukemia;
35(12): 3444-3454, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34725454
10.
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Leukemia;
34(9): 2354-2363, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32647324
11.
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression.
Front Immunol;
9: 1492, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30013559
12.
Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma.
Front Oncol;
8: 508, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30460198
13.
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells.
Nat Commun;
8: 15663, 2017 06 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28580927
14.
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.
Oncotarget;
8(2): 3274-3288, 2017 Jan 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27906678
15.
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.
Oncoimmunology;
4(11): e1047580, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26451323
16.
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
Oncotarget;
6(30): 29833-46, 2015 Oct 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26284584
17.
Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method.
Exp Hematol;
37(6): 728-38, 2009 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19463773
18.
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
Blood;
110(3): 921-7, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17403919
19.
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells.
Eur J Immunol;
35(4): 1155-63, 2005 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15761844